BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 12172502)

  • 21. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro.
    Perchellet EM; Sperfslage BJ; Wang Y; Huang X; Tamura M; Hua DH; Perchellet JP
    Anticancer Drugs; 2002 Jul; 13(6):567-81. PubMed ID: 12172502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities.
    Wang B; Perchellet EM; Wang Y; Tamura M; Hua DH; Perchellet JP
    Anticancer Drugs; 2003 Aug; 14(7):503-14. PubMed ID: 12960734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syntheses, molecular targets and antitumor activities of novel triptycene bisquinones and 1,4-anthracenedione analogs.
    Hua DH; Lou K; Battina SK; Zhao H; Perchellet EM; Wang Y; Perchellet JP
    Anticancer Agents Med Chem; 2006 Jul; 6(4):303-18. PubMed ID: 16842233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
    Gewirtz DA
    Biochem Pharmacol; 1999 Apr; 57(7):727-41. PubMed ID: 10075079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, molecular targets, and antitumor activities of substituted tetrahydro-1-oxopyrano[4,3-b][1]benzopyrans and nanogels for drug delivery.
    Perchellet EM; Perchellet JP; Ganta CK; Troyer DL; Shi A; Hua DH
    Anticancer Agents Med Chem; 2009 Oct; 9(8):864-76. PubMed ID: 19538164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of action and mechanism of resistance to antineoplastic agents that bind to DNA.
    Di Marco A
    Antibiot Chemother (1971); 1978; 23():216-27. PubMed ID: 348080
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.